Paul Isaac
Arbiter Partners Capital Management
Paul Isaac Laboratory Corp of America Holdings stake
total: 298
Arbiter Partners Capital Management LH trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2023 Q2
- Held for:
- 5 quarters
- Latest activity:
- 2024 Q3
According to 2026 Q2 report, Paul Isaac doesn't hold any Laboratory Corp of America Holdings (LH) shares. To date, the estimated cost basis is nearly $241.33 for "buy" trades and estimated average "sell" price is $203.51. Arbiter Partners Capital Management first purchased LH in 2023 Q2, initially acquiring 8,100 shares. Since the initial investment in Laboratory Corp of America Holdings (LH), Arbiter Partners Capital Management has made 1 more transaction.
When did Paul Isaac sell Laboratory Corp of America Holdings (LH)?
Paul Isaac sold off the entire Laboratory Corp of America Holdings (LH) position in 2024 Q3.
When did Paul Isaac buy Laboratory Corp of America Holdings (LH)?
Paul Isaac first invested in Laboratory Corp of America Holdings (LH) in 2023 Q2 at the reported quarter-end price of $241.33 per share.
What's the cost basis of Arbiter Partners Capital Management's LH stake?
The estimated cost basis for Laboratory Corp of America Holdings (LH) stake is around $241.33 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $241.33
- Weighted AVG sell price:
- $203.51
Paul Isaac's historical trades in Laboratory Corp of America Holdings
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q3
|
0.00%
|
0
|
$203.51
|
|
-100% (-8,100)
|
-3.33%
|
|
2023 Q2
|
3.28%
|
8,100
|
$241.33
|
$1,954,773
|
new
|
+3.28%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.